Accepted for/Published in: JMIR Research Protocols
Date Submitted: Jul 24, 2024
Date Accepted: Dec 5, 2024
Blended care intervention for cancer aftercare in general practice centres: a study protocol for a randomised controlled trial
ABSTRACT
Background:
Combining effective eHealth programs with face-to-face consultations in general practice may help general practitioners (GPs) to care for cancer survivors.
Objective:
This study protocol describes a two-armed randomised controlled trial (RCT) to evaluate (cost-)effectiveness of a blended intervention integrating the Cancer Aftercare Guide (CAG) in general practice centres (GPCs).
Methods:
In a parallel group design, an intervention group will be compared with a waiting list control group. Participants will be nested within GPCs and randomisation will take place at the GPC level. Participants in the intervention group will receive a blended care intervention, participants in the waiting list control group will receive care as usual for the duration of the study and will receive the online intervention afterwards. A process evaluation is also included in the study.
Results:
The study is ongoing, data is currently being collected. The anticipated end date is 21 March 2025.
Conclusions:
Results will provide insight in the effectiveness of blended care and may be relevant to cancer aftercare, general practice, and the field of eHealth implementation in general. Potential challenges lie in recruitment due to the strain on the healthcare system since the COVID-19 pandemic. Clinical Trial: The study is registered with the International Standard Randomised Controlled Trial Number (ISRTCN, ID: ISRCTN12451453, registration date 15-12-2021, last edited: 12-09-2023).
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.